# Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)

> **NCT00802906** · NA · COMPLETED · sponsor: **Johann Wolfgang Goethe University Hospital** · enrollment: 12 (actual)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **DEVICE:** subthreshold micropulselaser
- **DRUG:** bevacizumab

## Key facts

- **NCT ID:** NCT00802906
- **Lead sponsor:** Johann Wolfgang Goethe University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00802906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00802906, "Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00802906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*